BSEBoard Meeting3d ago · 3 Nov 2026, 06:17 pm

Outcome for the Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026

Amrutanjan Health Care Ltd-$ · 590006

✦ AI Summary▲ PositiveResults

Amrutanjan Health Care Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of Rs. 2,916.53 lakhs. The company has also declared a first interim dividend of Re.1/- per share for the financial year 2026-27.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Amrutanjan Health Care Ltd-$ - 590006 - Board Meeting Outcome for Outcome For The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026

Attachments (1)

📄

d200d9fb-612f-484a-80b4-0475d50adca9.pdf

pdf

Download →
View document text
AHCL/ SE/35/2026-27 November 3, 2026 The National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1st Floor, P.J. Towers, Dalal Street, Mumbai 400 051 Mumbai 400 001 ISIN: INE098F01031 ISIN: INE098F01031 Symbol: AMRUTANJAN Scrip Code: 590006 Dear Sir / Madam, Sub: Outcome of the Board Meeting In terms of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today 3rd November 2026 had inter-alia: (i) Approved the Unaudited Financial Results for the quarter and half year ended September 30, 2026, as recommended by the Audit Committee at its meeting held today 3rd November 2026, the same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared First Interim Dividend of Re.1/- per share for the financial year 2026-27 on the Equity Shares of the Company. The Board Meeting commenced at 12:00 P.M and concluded at 6.00 P.M. Request you to kindly take the same on record. Thanking you, Yours faithfully, For Amrutanjan Health Care Limited Gagan Preet Singh General Manager - Legal Company Secretary and Compliance Officer Encl: 1. Un-audited Standalone Financials Results for the quarter ended September 30, 2026 2. Limited Review Report Amrutanjan Health Care Limited I 03, (Old No. 42-45), Luz Church Road, E-mail : customercare@amrutanjan.com Mylapore, Chennai - 600 004 WebSite : www. amrutanjan.com Tamil Nadu, India. Toll Free No.: I • 800 - 425 - 4545 Tel :+91-44 - 2499 4465 CIN - L24231TN1936PLC000017 +91-44 • 2466 9000 Fax :+91-44 - 2499 4585 AMRUTANJAN HEALTH CARE LIMITED CIN No : L24231TN1936PLC000017 Registered Office: No. 103 (Old No. 42-45), Luz Church Road MvlaDOre Chennai -600 004 Note 1: Statement of assets and liabilities (Amount In INR In Lalchs) As at Asat S.No. Particulars 30 Seotember 2026 31 March 2026 (Unaudited) /Audltedl A ASSETS 1 Non-current assets (a) Property, plant and equipment 15,833.14 4,829.93 (b) Rlght--Of-use assets 1,074.22 150.81 (c) Capital work in progress 1,947.37 10,547.98 (d) Intangible assets 136.78 144.75 (e) Intangible assets under development 23.70 23.70 (f) Financial assets Investments 4.11 4.67 Other financial assets 690.36 4,619.09 (g) Deferred tax assets (net) 253.31 531.46 (h) Other tax assets (net) 536.69 290.56 (i) Other non-current assets 493.19 581.53 Total non-current assets 20,992.87 21724.48 2 Current assets (a) Inventories 5,808.60 3,735.04 (b) Financial assets (/) Investments 316.07 307.40 (ii) Trade receivables 4,442.42 6,064.40 (Iii) Cash and cash equivalents 796.45 1,127.23 (Iv) Bank balances other than (iii) above 1,512.09 2,205.23 (v) Other financial assets 15,923.57 14,234.00 (c) Other current assets 1 716.72 1,491.32 Total current assets 30,515.92 29,164.62 Total assets (1+21 51,508.79 50,889.10 B EQUITY AND LtABIUTtES 1 Equity (a) Equity share capital 289.11 289.11 (b) Other equity 38 104.80 36 734.15 Total equity 38,393.91 37,023.26 Liabilities 2 Non-current liabilities (a) Financial liabilities Lease liabilities 152.45 142.32 Other financial liabilities 55.27 103.06 (b) Provisions 1 074.54 1 002.01 Total non-current liabilities 1,282.26 1,247.39 3 Current liabilities (a) Financial liabilities Lease liabilities 36.56 35.42 Trade payables total outstanding dues of micro enterprises and small enterprises 447.70 337.50 total outstanding dues of creditors other than micro enterprises and small enterprises 5,891.17 6,752.00 Other financial liabilities 3,836.57 2,936.74 (b) Other current liabilities 718.16 992.85 (c) Provisions 330.40 1,056.68 (d) Current tax liabilites (net) 572.06 507.26 Total current liabilities 11,832.62 12,618.45 Total liablllties (2+3) 13,114.88 13,865.84 Total eauitv and liabilities 11+2+31 51,508.79 50,889.10 AMRUTANJAN HEALTH CARE LIMITED CIN No : L24231TN1936PLC000017 Regislered Office: No. 103 (Old No. 42-45), Luz Church Road M,ta-Chennai -600 004 Note 2: Statement of Cash flows (Amount In INR in Lakhs/ For the half year ended For the half year ended For the year ended Particulars 30 September 2026 30 September 2025 31 March 2026 <Unaudited\ <Unaudited\ (Audited) Cash flow from operating activities Profit before tax 2,916.53 3,050.76 7,788.78 Adjustments for: Depreciation and amortisation expense 540.57 308.84 631.90 Loss J {Profit) on sale of property, plant and equipment 1.79 (10.38) (10.38) EquHy-setued share-based payment transactions 47.32 87.88 (93.42) Loss allowance on trade receivables 118.45 43.20 91.52 Bed debts Mitten off 0.15 0.15 Change in fair value of financial assets at FVTPL (8.11) 0.18 (7.56) Interest income on cash and cash equivalents and other bank balances (516.97) (738.26) (1,473.71) Interest income on corporate debt seculities and loans at amortised cost (73.46) (79.15) (118.33) Excess provision written back, net (33.92) (21.22) (107.20) Gain on surrender of lease (1.92) Finance costs 8.86 10.12 19.50 Operating profit before working capHal I other changes 2,999.14 2,652.12 6,721.25 Working capital adjustments: Decrease/ (Increase) in trade receivables 1,503.53 1,708.45 (573.89) (Increase) In other assets (239.38) (266.19) (904.87) (Increase) In other financial assels (41.80) (11.29) (50.95) (Increase) in inventories (2,073.56) (824.13) (1,009.06) (Decrease) in other financial liabilities (60.75) (68.75) - (Decf'&ase) / Increase in provisions (657.53) 74.17 976.65 (Decrease)/ Increase in trade payables (716.71) (1,082.70) 292.43 (Decrease)/ Increase in other liabilities i214.69i '216.18 48.28 (2,560.89) (686.62) (1,221.41) Cash generated from operating activities 438.25 1,965.50 5,499.84 Less: Income tax paid (net) '654.20 1874.781 f1 903.07 Net cash (used in)/ generated from operating activities (a) 1215.95 1,090.72 3,596.77 Cash flows from Investing activities Purchase or construction of property, plant and equipment, intangible assets, capital w:Jrk-in progress, intangible assets under development, right o (3,648.39) (1,872.88) (5,500.38) use assets, movement in capital advances and payable towards purchase of property, plant and equipment (including retention payable) Proceeds from sale of Property, plant and equipment 0.41 10.38 10.38 Redemption/ (Investment) in bank deposits and financial institutions 3,800.33 486.29 2,075.09 Interest received on deposits with banks and financial institutions, net 590.43 554.60 1,592.04 (lnvesbnents made) I Proceeds from redemption of investments (30000 Net cash generated from I (used In) Investing activities (b) 742.78 1821.61 12,122.37 Cash flow from financing activities Dividend paid (832.32) (751.68) (1,319.80) Sale of shares by employee stock option trust 6.95 7.18 Payment of lease liabilities 125.29 124.681 149.57 Net cash (used In) financing activities (c) 1857.61 1769.41) 11 362.19 Net change In cash and cash equivalents (a)+ (b) + (c) (330.78 1500.30) 111.71 Cash and cash equivalents at the beginning of the year 1,127.23 1,015.52 1,015.52 Effect of exchange rate fluctuations on cash held Cash and cash equivalents at the end of the period 796.45 515.22 1,127.23 Components of cash and cash equivalents Cash on hand 4.33 4.87 3.06 Bank balances 792.12 510.35 1,124.17 Cash and cash eq~_ivalente as par Statement of assets and llabllltlas 796.45 515.22 1,127.23 Note: The above cash flow statement has been prepared under the •indirect method· as set out in the Ind AS 7 on statement of Cash Flows specified under section 133 of the Companies Act, 2013 .,--;,ryl AMRUT ANJAN HEAL TH CARE LIMITED CIN No : L24231TN1936PLC000017 Registered Office: No. 103 (Old No. 42-45), Luz Church Road M..iannrA. Chennal • 600 004 Statement of Unaudited Financial Results for Iha auartar and half vear anded 30 Seotember 2026 /Amount In /NR In t.akhsl Particulars Quarter ended Half vear ended Year ended 30 September 2026 30 June 2026 3 [Showing first 8,000 characters — download PDF for full document]